Author |
Title |
JournalName |
Year D |
Click on Column Headers to Re-Sort The Current List |
LEIN OG, SHULGIN AT, GAL ... |
Feasibility of quantitative separation of the threo- and erythro-forms... |
Nature |
1952 |
Rinkel M, Atwell CR, Dima... |
Experimental Psychiatry. V. Psilocybine, A New Psychotogenic Drug |
New England J. Med. |
1960 |
Fox RP |
A physician's guide to LSD |
GP |
1967 |
Connell PH |
Hallucinogens |
Side effects of drug... |
1972 |
Nichols DE, Barfknecht CF... |
Asymmetric synthesis of psychotomimetic phenylisopropylamines |
J Med Chem |
1973 |
Nichols DE |
Potential Psychotomimetics Bromomethoxyamphetamines And Structural Con... |
Diss.Abstr.Intern. B |
1973 |
Jarvik JF, Yen FS, Dahlbe... |
Chromosome Examinations After Medically Administered Lysergic Acid Die... |
Dis Nerv Syst |
1974 |
Fillion G, Fillion MP, Sp... |
5-Hydroxytryptamine Binding to Synaptic Membranes from Rat Brain |
Life Sci. |
1976 |
M. Repetto, M. Lopez-Arti... |
Separation of cannabinoids |
Bulletin on Narcotic... |
1976 |
Halaris AE, Freedman DX |
Vesicular And Juxtavesicular Serotonin: Effects Of Lysergic Acid Dieth... |
J Pharmacol Exp Ther... |
1977 |
HARTIG PR, KADAN MJ, EVAN... |
125-i-LSD: A High Sensitivity Ligand For Serotonin Receptors |
European Journal of ... |
1983 |
Renfroe CL |
MDMA on the street: Analysis Anonymous |
J Psychoactive Drugs |
1986 |
Stanford MW |
Designer drugs: Medical aspects and clinical management |
Alcoholism Treatment... |
1988 |
Wohlberg J |
Haoma-Soma in the world of ancient Greece |
J Psychoactive Drugs |
1990 |
Wohlberg J |
Haoma-Soma in the world of ancient Greece |
J Psychoactive Drugs |
1990 |
Barrett PJ |
'Ecstasy' misuse--overdose or normal dose? |
Anaesthesia |
1993 |
Abrahart D |
A Critical Review of Theories and Research Concerning Lysergic Acid Di... |
Masters Thesis |
1998 |
Rashed AM, Anderson RA, K... |
Solid-phase extraction for profiling of ecstasy tablets |
J Forensic Sci |
2000 |
Vastag B |
Ecstasy experts want realistic messages |
JAMA |
2001 |
Puthaviriyakorn V, Sirivi... |
Identification of impurities and statistical classification of methamp... |
Forensic Sci Int |
2002 |
Simonsen KW, Kaa E, Niels... |
Narcotics at street level in Denmark. A prospective investigation from... |
Forensic Sci Int |
2003 |
Parrott AC |
Is ecstasy MDMA? A review of the proportion of ecstasy tablets contain... |
Psychopharmacology (... |
2004 |
Tanner-Smith EE |
Pharmacological content of tablets sold as 'ecstasy': results from an ... |
Drug Alcohol Depend |
2006 |
Wolowich WR, Perkins AM, ... |
Analysis of the psychoactive terpenoid salvinorin A content in five Sa... |
Pharmacotherapy |
2006 |
Fucci N |
Unusual adulterants in cocaine seized on Italian clandestine market |
Forensic Sci Int |
2007 |
Behrman AD |
Luck of the draw: common adulterants found in illicit drugs |
J Emerg Nurs |
2008 |
Nichols DE, Frescas SP, C... |
High specific activity tritium-labeled N-(2-methoxybenzyl)-2,5-dimetho... |
Bioorg Med Chem |
2008 |
Andreasen MF, Telving R, ... |
A fatal poisoning involving Bromo-Dragonfly |
Forensic Sci Int |
2009 |
Duterte M, Jacinto C, Sal... |
What's in a label? Ecstasy sellers' perceptions of pill brands |
J Psychoactive Drugs |
2009 |
Westphal F, Junge T, Girr... |
Structure elucidation of a new designer benzylpiperazine: 4-bromo-2,5-... |
Forensic Sci Int |
2009 |
Vogels N, Brunt TM, Rigte... |
Content of ecstasy in the Netherlands: 1993-2008 |
Addiction |
2009 |
Gibbons S, Zloh M |
An analysis of the 'legal high' mephedrone |
Bioorg Med Chem Lett |
2010 |
Brandt SD, Sumnall HR, Me... |
The confusing case of NRG-1 |
BMJ |
2010 |
Schifano F, Albanese A, F... |
Mephedrone 4-methylmethcathinone 'meow meow': chemical, pharmacologica... |
Psychopharmacology B... |
2010 |
Carhart-Harris RL, King L... |
A web-based survey on mephedrone |
Drug Alcohol Depend |
2011 |
Baron M, Elie M, Elie L |
An analysis of legal highs-do they contain what it says on the tin? |
Drug Test Anal |
2011 |
Archer RP, Treble R, Will... |
Reference materials for new psychoactive substances |
Drug Test Anal |
2011 |
Bruno R, Matthews AJ, Dun... |
Emerging psychoactive substance use among regular ecstasy users in Aus... |
Drug Alcohol Depend |
2011 |
Tupper KW |
Sex, drugs and the honour roll: the perennial challenges of addressing... |
Critical Public Heal... |
2013 |
Moore K, Dargan PI, Wood ... |
Do novel psychoactive substances displace established club drugs, supp... |
Eur Addict Res |
2013 |
Nelson ME, Bryant SM, Aks... |
Emerging drugs of abuse |
Emerg Med Clin North... |
2014 |
Van Hout MC |
An Internet Study of User's Experiences of the Synthetic Cathinone 4-M... |
J Psychoactive Drugs |
2014 |
Palamar JJ, Salomone A, V... |
Detection of bath salts and other novel psychoactive substances in hai... |
Drug Alcohol Depend |
2016 |
Brunt TM, Nagy C, Bücheli... |
Drug testing in Europe: monitoring results of the Trans European Drug ... |
Drug Test Anal |
2016 |
Vidal C, Ventura M, Forní... |
Crystals and tablets in the Spanish ecstasy market 2000-2014: Are they... |
Forensic Science Int... |
2016 |
Caudevilla F, Ventura M, ... |
Results of an international drug testing service for cryptomarket user... |
Int. J. Drug Policy |
2016 |
Palamar JJ |
There's Something About Molly: The Under-Researched yet Popular Powder... |
Subst Abus |
2016 |
Dasgupta N, Gilbert M |
Commentary van der Gouwe et al(2017): Drug-testing services and crypto... |
Addiction |
2017 |
van der Gouwe D, Brunt TM... |
Purity, adulteration and price of drugs bought online versus offline i... |
Addiction |
2017 |
Assi S, Gulyamova N, Knel... |
The effects and toxicity of cathinones from the users' perspectives: A... |
Hum Psychopharmacol |
2017 |
Guirguis A, Corkery JM, S... |
Intended and unintended use of cathinone mixtures |
Hum Psychopharmacol |
2017 |
Heather E, Shimmon R, McD... |
Organic Impurity Profiling of 3,4-Methylenedioxymethamphetamine ... |
Forensic Sci Int |
2020 |
Cozzi NV, Daley PF |
Synthesis and characterization of high-purity N,N-dimethyltryptamine h... |
Drug Test Anal |
2020 |
Sherwood AM, Claveau R, L... |
Synthesis and Characterization of 5-MeO-DMT Succinate for Clinical Use |
ACS Omega |
2020 |